Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian De

Showing results (171-180 of 183) with videos related to

Pageof 19
Sort By:
Journal of Hepatocellular Carcinoma|March 10, 2021
Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with RadiotherapyBrian De, Sweet Ping Ng, Amy Y Liu, et al.
Journal of Personalized Medicine|December 24, 2021
Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic CholangiocarcinomaBrian De, Ibrahim Abu-Gheida, Aashini Patel, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|January 28, 2014
One-stage versus two-stage exchangePaul Lichstein, Thorsten Gehrke, Adolph Lombardi, et al.
The Journal of Arthroplasty|December 24, 2013
One-stage vs two-stage exchangePaul Lichstein, Thorsten Gehrke, Adolph Lombardi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2026
Clinicogenomic and Histopathologic Analyses of Supermassive Intrahepatic Cholangiocarcinoma and the Role of Ablative RadiotherapyJoseph Abi Jaoude, Alexandria Lau, Yinyin Yuan, et al.
NPJ Systems Biology and Applications|December 12, 2025
Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of responseBrian De, Prashant Dogra, Mohamed Zaid, et al.
Medrxiv : the Preprint Server for Health Sciences|September 24, 2024
Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of responseBrian De, Prashant Dogra, Mohamed Zaid, et al.
Liver Cancer|August 18, 2023
Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic MetastasesBrian De, Rituraj Upadhyay, Kaiping Liao, et al.
International Journal of Radiation Oncology, Biology, Physics|March 25, 2022
Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic FactorsPaul W Sperduto, Brian De, Jing Li, et al.
Journal of Neuro-Oncology|November 5, 2025
Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses : Treatment intensification, margin reduction and epigenetic stratified outcomes with radiation therapy and chemotherapyDebra Nana Yeboa, Benjamin T Whitfield, Ruitao Lin, et al.
Pageof 19

Showing results (171-180 of 183) with videos related to

Sort By:
Pageof 19
Journal of Hepatocellular Carcinoma|March 10, 2021
Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with RadiotherapyBrian De, Sweet Ping Ng, Amy Y Liu, et al.
Journal of Personalized Medicine|December 24, 2021
Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic CholangiocarcinomaBrian De, Ibrahim Abu-Gheida, Aashini Patel, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|January 28, 2014
One-stage versus two-stage exchangePaul Lichstein, Thorsten Gehrke, Adolph Lombardi, et al.
The Journal of Arthroplasty|December 24, 2013
One-stage vs two-stage exchangePaul Lichstein, Thorsten Gehrke, Adolph Lombardi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2026
Clinicogenomic and Histopathologic Analyses of Supermassive Intrahepatic Cholangiocarcinoma and the Role of Ablative RadiotherapyJoseph Abi Jaoude, Alexandria Lau, Yinyin Yuan, et al.
NPJ Systems Biology and Applications|December 12, 2025
Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of responseBrian De, Prashant Dogra, Mohamed Zaid, et al.
Medrxiv : the Preprint Server for Health Sciences|September 24, 2024
Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of responseBrian De, Prashant Dogra, Mohamed Zaid, et al.
Liver Cancer|August 18, 2023
Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic MetastasesBrian De, Rituraj Upadhyay, Kaiping Liao, et al.
International Journal of Radiation Oncology, Biology, Physics|March 25, 2022
Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic FactorsPaul W Sperduto, Brian De, Jing Li, et al.
Journal of Neuro-Oncology|November 5, 2025
Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses : Treatment intensification, margin reduction and epigenetic stratified outcomes with radiation therapy and chemotherapyDebra Nana Yeboa, Benjamin T Whitfield, Ruitao Lin, et al.
Pageof 19